期刊文献+

肠型白塞病合并带状疱疹1例及相关文献复习 被引量:5

下载PDF
导出
摘要 患者,男,33岁。因反复口腔溃疡15年,回盲部溃疡4年,于2015年10月21日收住我院。患者15年前无明显诱因出现复发性口腔溃疡,每年10余次,每次1-3处,伴疼痛。溃疡主要累及唇、颊、颚、牙龈、咽后壁,病程1-2周。患者无外阴溃疡发作,无眼炎。针刺反应(+)。4年前因腹痛查肠镜显示:回盲部巨大不规则溃疡,活检病理提示:黏膜重度慢性炎性反应伴感染坏死。患者不规则服用柳氮磺胺吡啶,控制不佳。1年前患者腹痛再次发作,就诊于我院,行肠镜复查,
出处 《疑难病杂志》 CAS 2016年第6期642-643,F0003,共3页 Chinese Journal of Difficult and Complicated Cases
基金 上海卫生系统第二批重要疾病联合攻关重点项目(2014ZYJB0010)
  • 相关文献

参考文献17

  • 1M1ZUKI N,MEGURO A,OTA M,et al.Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci[J].Nat Genet,2010,42(8):703-706.
  • 2DISEASE I F.Criteria for diagnosis of Behcet's disease[J].Lancet,1990,335(8697):1078-1080.
  • 3SIVA A,KANTARCI O H,SAIP S,et al.Behcet's disease:diagnostic and prognostic aspects of neurological involvement[J].J Neurol,2001,248(2):95-103.
  • 4TURSEN U,PISK1N G,LOTTI T,et al.Pathological and immunological developments in behcet's disease[J].Patholog Res Int,2012.doi:10.1155/2012/305780.
  • 5EKIZ O,BALTA I,SEN B B,et al.The etiology of Behcet disease:is it really inflammation or not[J].Angiology,2014,65(4):327.
  • 6HUGHES T,COIT P,ADLER A,et al.Identification of multiple Independent susceptibility loci in the HLA region in Behcet's disease[J].Nat Genet,2013,45(3):319-324.
  • 7SEZER F N.The isolation of a virus as the cause of Behcet's diseases[J].Am J Ophthalmol,1953,36(3):301-315.
  • 8PINETON DE GHAMBRUN M,WECHSLER B,GERI G,et al.New insights into the pathogenesis of Behcet's disease[J].Autoimmun Rev,2012,11(10):687-698.
  • 9SEBAHATT1N Y,HASAN Y.Behcet's syndrome[J].Best Pract Res Clin Rheumatol,2008,58(30):1272-1278.
  • 10陈志涵,林禾,高飞.英夫利昔单抗治疗肠白塞病二例并文献复习[J].中国全科医学,2014,17(36):4350-4352. 被引量:4

二级参考文献8

  • 1Misumi M, Hagiwara E, Takeno M, et al. Cytokine production profile in patients with Behcet's disease treated with infliximab [J]. Cytokine, 2003, 24 (5): 210-218.
  • 2Hassard PV, Binder SW, Nelson V, et al. Anti - tumor necrosis factor monoclonal antibody therapy for gastrointestinal Beheet's disease: a case report [J]. Gastroenterology, 2001, 120 (4): 995-999.
  • 3Byeon JS, Choi EK, Heo NY, et al. Antitumor necrosis factor - alpha therapy for early postoperative recurrence of gastrointestinal Behcet's dis-ease: report ofaease IJl- Dis Colon Rectum, 2007, 50 (5): 672 - 676.
  • 4Iwata S, Saito K, Yamaoka K, et al. Efficacy of combination therapy of anti- TNF-α antibody infliximab and methotrexate in refractory entem -Behcet's disease [J]. Mod Rheumatol, 2011, 21 (2): 184- 191.
  • 5Maruyama Y, Hisamatsu T, Matsuoka K, et al. A case of intestinal Be- hcet's disease treated with infliximab monotherapy who successfully main- tained clinical remission and complete mucosal healing for six years [J]. Intern Med, 2012, 51 (16): 2125-2129.
  • 6Lee JH, Cheon JH, Jeon SW, et al. Efficacy of infliximab in intestinal Behcet's disease: a Korean muhicenter retrospective study [ J]. In- flamm Bowel Dis, 2013, 19 (9) : 1833 - 1838.
  • 7Sfikakis PP, Markomichelakis N, Alpsoy E, et al. Anti -TNF therapy in the management of Behcet's disease - review and basis for recommen- dations [J]. Rheumatology: Oxford, 2007, 46 (5): 736-741.
  • 8Hisamatsu T, Ueno F, Matsurnoto T, et al. The 2nd edition of consen- sus statements for the diagnosis and management of intestinal Beheet's disease : indieation of anti - TNFα rnonoelonal antibodies [ J ]. J Gas- troenterol, 2014, 49 (1) : 156 - 162.

共引文献3

同被引文献40

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部